메뉴 건너뛰기




Volumn 28, Issue 2, 2014, Pages 67-74

Diagnosis and management of complement mediated thrombotic microangiopathies

Author keywords

ADAMTS13; Atypical hemolytic uremic syndrome; Complement activation; Diagnosis; Thrombotic thrombocytopenic purpura

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; CREATININE; ECULIZUMAB; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

EID: 84896078812     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2014.01.003     Document Type: Article
Times cited : (37)

References (58)
  • 1
    • 84878589219 scopus 로고    scopus 로고
    • Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
    • Legendre C.M., Licht C., Muus P., Greenbaum L.A., Babu S., Bedrosian C., et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013, 368:2169-2181.
    • (2013) N Engl J Med , vol.368 , pp. 2169-2181
    • Legendre, C.M.1    Licht, C.2    Muus, P.3    Greenbaum, L.A.4    Babu, S.5    Bedrosian, C.6
  • 2
    • 70350279315 scopus 로고    scopus 로고
    • Atypical hemolytic-uremic syndrome
    • Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009, 361:1676-1687.
    • (2009) N Engl J Med , vol.361 , pp. 1676-1687
    • Noris, M.1    Remuzzi, G.2
  • 3
    • 77954086014 scopus 로고    scopus 로고
    • Thrombotic microangiopathies: new insights and new challenges
    • Zipfel P.F., Heinen S., Skerka C. Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens 2010, 19:372-378.
    • (2010) Curr Opin Nephrol Hypertens , vol.19 , pp. 372-378
    • Zipfel, P.F.1    Heinen, S.2    Skerka, C.3
  • 4
    • 70349437186 scopus 로고    scopus 로고
    • Complement regulators and inhibitory proteins
    • Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9:729-740.
    • (2009) Nat Rev Immunol , vol.9 , pp. 729-740
    • Zipfel, P.F.1    Skerka, C.2
  • 5
    • 0025999820 scopus 로고
    • Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients
    • Bell W.R., Braine H.G., Ness P.M., Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991, 325:398-403.
    • (1991) N Engl J Med , vol.325 , pp. 398-403
    • Bell, W.R.1    Braine, H.G.2    Ness, P.M.3    Kickler, T.S.4
  • 6
    • 0034663327 scopus 로고    scopus 로고
    • How I, treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
    • George J.N. How I, treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000, 96:1223-1229.
    • (2000) Blood , vol.96 , pp. 1223-1229
    • George, J.N.1
  • 7
    • 61549117207 scopus 로고    scopus 로고
    • Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
    • Ariceta G., Besbas N., Johnson S., Karpman D., Landau D., Licht C., et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009, 24:687-696.
    • (2009) Pediatr Nephrol , vol.24 , pp. 687-696
    • Ariceta, G.1    Besbas, N.2    Johnson, S.3    Karpman, D.4    Landau, D.5    Licht, C.6
  • 8
    • 0023689035 scopus 로고
    • Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology
    • Loirat C., Sonsino E., Hinglais N., Jais J.P., Landais P., Fermanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 1988, 2:279-285.
    • (1988) Pediatr Nephrol , vol.2 , pp. 279-285
    • Loirat, C.1    Sonsino, E.2    Hinglais, N.3    Jais, J.P.4    Landais, P.5    Fermanian, J.6
  • 9
    • 0023929294 scopus 로고
    • Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial
    • Rizzoni G., Claris-Appiani A., Edefonti A., Facchin P., Franchini F., Gusmano R., et al. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr 1988, 112:284-290.
    • (1988) J Pediatr , vol.112 , pp. 284-290
    • Rizzoni, G.1    Claris-Appiani, A.2    Edefonti, A.3    Facchin, P.4    Franchini, F.5    Gusmano, R.6
  • 10
    • 58249107186 scopus 로고    scopus 로고
    • Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials
    • Michael M., Elliott E.J., Craig J.C., Ridley G., Hodson E.M. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis 2009, 53:259-272.
    • (2009) Am J Kidney Dis , vol.53 , pp. 259-272
    • Michael, M.1    Elliott, E.J.2    Craig, J.C.3    Ridley, G.4    Hodson, E.M.5
  • 11
    • 67049161222 scopus 로고    scopus 로고
    • Thrombotic microangiopathy: what not to learn from a meta-analysis
    • Noris M., Remuzzi G. Thrombotic microangiopathy: what not to learn from a meta-analysis. Nat Rev Nephrol 2009, 5:186-188.
    • (2009) Nat Rev Nephrol , vol.5 , pp. 186-188
    • Noris, M.1    Remuzzi, G.2
  • 12
    • 33747159590 scopus 로고    scopus 로고
    • Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
    • Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006, 108:1267-1279.
    • (2006) Blood , vol.108 , pp. 1267-1279
    • Caprioli, J.1    Noris, M.2    Brioschi, S.3    Pianetti, G.4    Castelletti, F.5    Bettinaglio, P.6
  • 13
    • 84877733678 scopus 로고    scopus 로고
    • Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation
    • Carr R., Cataland S.R. Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation. Ann Hematol 2013, 92:845-846.
    • (2013) Ann Hematol , vol.92 , pp. 845-846
    • Carr, R.1    Cataland, S.R.2
  • 14
    • 84877018743 scopus 로고    scopus 로고
    • Profound neurological injury in a patient with atypical hemolytic uremic syndrome
    • Salem G., Flynn J.M., Cataland S.R. Profound neurological injury in a patient with atypical hemolytic uremic syndrome. Ann Hematol 2013, 92:557-558.
    • (2013) Ann Hematol , vol.92 , pp. 557-558
    • Salem, G.1    Flynn, J.M.2    Cataland, S.R.3
  • 15
    • 84896101449 scopus 로고    scopus 로고
    • Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases
    • Fakhouri F., Delmas Y., Provot F., Barbet C., Karras A., Makdassi R., et al. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases. Am J Kidney Dis 2014, 63:40-48.
    • (2014) Am J Kidney Dis , vol.63 , pp. 40-48
    • Fakhouri, F.1    Delmas, Y.2    Provot, F.3    Barbet, C.4    Karras, A.5    Makdassi, R.6
  • 16
    • 0036683408 scopus 로고    scopus 로고
    • Von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
    • Remuzzi G., Galbusera M., Noris M., Canciani M.T., Daina E., Bresin E., et al. Von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 2002, 100:778-785.
    • (2002) Blood , vol.100 , pp. 778-785
    • Remuzzi, G.1    Galbusera, M.2    Noris, M.3    Canciani, M.T.4    Daina, E.5    Bresin, E.6
  • 17
    • 84883557853 scopus 로고    scopus 로고
    • Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies
    • Cataland S.R., Wu H.M. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies. Eur J Intern Med 2013, 24:486-491.
    • (2013) Eur J Intern Med , vol.24 , pp. 486-491
    • Cataland, S.R.1    Wu, H.M.2
  • 18
    • 34548400755 scopus 로고    scopus 로고
    • Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background
    • Bresin E., Daina E., Noris M., Castelletti F., Stefanov R., Hill P., et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 2006, 1:88-99.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 88-99
    • Bresin, E.1    Daina, E.2    Noris, M.3    Castelletti, F.4    Stefanov, R.5    Hill, P.6
  • 19
    • 49349112382 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome recurrence after renal transplantation
    • Loirat C., Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 2008, 12:619-629.
    • (2008) Pediatr Transplant , vol.12 , pp. 619-629
    • Loirat, C.1    Fremeaux-Bacchi, V.2
  • 20
    • 70349923265 scopus 로고    scopus 로고
    • A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure
    • Lhotta K., Janecke A.R., Scheiring J., Petzlberger B., Giner T., Fally V., et al. A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clin J Am Soc Nephrol 2009, 4:1356-1362.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1356-1362
    • Lhotta, K.1    Janecke, A.R.2    Scheiring, J.3    Petzlberger, B.4    Giner, T.5    Fally, V.6
  • 21
    • 2542490269 scopus 로고    scopus 로고
    • Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
    • Zheng X.L., Kaufman R.M., Goodnough L.T., Sadler J.E. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004, 103:4043-4049.
    • (2004) Blood , vol.103 , pp. 4043-4049
    • Zheng, X.L.1    Kaufman, R.M.2    Goodnough, L.T.3    Sadler, J.E.4
  • 22
    • 3242705780 scopus 로고    scopus 로고
    • Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement
    • Coppo P., Bengoufa D., Veyradier A., Wolf M., Bussel A., Millot G.A., et al. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore) 2004, 83:233-244.
    • (2004) Medicine (Baltimore) , vol.83 , pp. 233-244
    • Coppo, P.1    Bengoufa, D.2    Veyradier, A.3    Wolf, M.4    Bussel, A.5    Millot, G.A.6
  • 24
    • 79952249613 scopus 로고    scopus 로고
    • Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
    • Jang M.J., Chong S.Y., Kim I.H., Kim J.H., Jung C.W., Kim J.Y., et al. Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience. Int J Hematol 2011, 93:163-169.
    • (2011) Int J Hematol , vol.93 , pp. 163-169
    • Jang, M.J.1    Chong, S.Y.2    Kim, I.H.3    Kim, J.H.4    Jung, C.W.5    Kim, J.Y.6
  • 25
    • 84858022582 scopus 로고    scopus 로고
    • Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan
    • Matsumoto M., Bennett C.L., Isonishi A., Qureshi Z., Hori Y., Hayakawa M., et al. Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS One 2012, 7:e33029.
    • (2012) PLoS One , vol.7
    • Matsumoto, M.1    Bennett, C.L.2    Isonishi, A.3    Qureshi, Z.4    Hori, Y.5    Hayakawa, M.6
  • 26
    • 77956532403 scopus 로고    scopus 로고
    • Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience
    • Coppo P., Schwarzinger M., Buffet M., Wynckel A., Clabault K., Presne C., et al. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One 2010, 5:e10208.
    • (2010) PLoS One , vol.5
    • Coppo, P.1    Schwarzinger, M.2    Buffet, M.3    Wynckel, A.4    Clabault, K.5    Presne, C.6
  • 28
    • 77958587405 scopus 로고    scopus 로고
    • Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
    • Noris M., Caprioli J., Bresin E., Mossali C., Pianetti G., Gamba S., et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010, 5:1844-1859.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1844-1859
    • Noris, M.1    Caprioli, J.2    Bresin, E.3    Mossali, C.4    Pianetti, G.5    Gamba, S.6
  • 29
    • 84880573893 scopus 로고    scopus 로고
    • Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab
    • Gulleroglu K., Fidan K., Hancer V.S., Bayrakci U., Baskin E., Soylemezoglu O. Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 2013, 28:827-830.
    • (2013) Pediatr Nephrol , vol.28 , pp. 827-830
    • Gulleroglu, K.1    Fidan, K.2    Hancer, V.S.3    Bayrakci, U.4    Baskin, E.5    Soylemezoglu, O.6
  • 30
    • 81255195666 scopus 로고    scopus 로고
    • Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
    • Ohanian M., Cable C., Halka K. Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report. Clin Pharmacol 2011, 3:45-50.
    • (2011) Clin Pharmacol , vol.3 , pp. 45-50
    • Ohanian, M.1    Cable, C.2    Halka, K.3
  • 31
    • 77949903692 scopus 로고    scopus 로고
    • Survival and relapse in patients with thrombotic thrombocytopenic purpura
    • quiz 662.
    • Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood.115:1500-11; quiz 662.
    • Blood , vol.115 , pp. 1500-1511
    • Kremer Hovinga, J.A.1    Vesely, S.K.2    Terrell, D.R.3    Lammle, B.4    George, J.N.5
  • 32
    • 0032569884 scopus 로고    scopus 로고
    • Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
    • Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998, 339:1578-1584.
    • (1998) N Engl J Med , vol.339 , pp. 1578-1584
    • Furlan, M.1    Robles, R.2    Galbusera, M.3    Remuzzi, G.4    Kyrle, P.A.5    Brenner, B.6
  • 33
    • 0032569840 scopus 로고    scopus 로고
    • Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
    • Tsai H.M., Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998, 339:1585-1594.
    • (1998) N Engl J Med , vol.339 , pp. 1585-1594
    • Tsai, H.M.1    Lian, E.C.2
  • 34
    • 0035885927 scopus 로고    scopus 로고
    • Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases
    • Veyradier A., Obert B., Houllier A., Meyer D., Girma J.P. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001, 98:1765-1772.
    • (2001) Blood , vol.98 , pp. 1765-1772
    • Veyradier, A.1    Obert, B.2    Houllier, A.3    Meyer, D.4    Girma, J.P.5
  • 35
    • 0037379399 scopus 로고    scopus 로고
    • Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura
    • Tsai H.M. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003, 14:1072-1081.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 1072-1081
    • Tsai, H.M.1
  • 36
    • 0142166256 scopus 로고    scopus 로고
    • Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No
    • Remuzzi G. Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No. J Thromb Haemost 2003, 1:632-634.
    • (2003) J Thromb Haemost , vol.1 , pp. 632-634
    • Remuzzi, G.1
  • 37
    • 84896078409 scopus 로고    scopus 로고
    • Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura
    • Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, et al. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica.
    • Haematologica
    • Froehlich-Zahnd, R.1    George, J.N.2    Vesely, S.K.3    Terrell, D.R.4    Aboulfatova, K.5    Dong, J.F.6
  • 38
    • 84861526957 scopus 로고    scopus 로고
    • Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
    • Chapin J., Weksler B., Magro C., Laurence J. Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura. Br J Haematol 2012, 157:772-774.
    • (2012) Br J Haematol , vol.157 , pp. 772-774
    • Chapin, J.1    Weksler, B.2    Magro, C.3    Laurence, J.4
  • 40
    • 84867993256 scopus 로고    scopus 로고
    • French Study Group for a HCG. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
    • Zuber J., Fakhouri F., Roumenina L.T., Loirat C., Fremeaux-Bacchi V. French Study Group for a HCG. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 2012, 8:643-657.
    • (2012) Nat Rev Nephrol , vol.8 , pp. 643-657
    • Zuber, J.1    Fakhouri, F.2    Roumenina, L.T.3    Loirat, C.4    Fremeaux-Bacchi, V.5
  • 41
    • 77949903692 scopus 로고    scopus 로고
    • Survival and relapse in patients with thrombotic thrombocytopenic purpura
    • quiz 662.
    • Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood.115:1500-11; quiz 662.
    • Blood , vol.115 , pp. 1500-1511
    • Hovinga, J.A.1    Vesely, S.K.2    Terrell, D.R.3    Lammle, B.4    George, J.N.5
  • 42
    • 1242344743 scopus 로고    scopus 로고
    • Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients
    • Raife T., Atkinson B., Montgomery R., Vesely S., Friedman K. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion 2004, 44:146-150.
    • (2004) Transfusion , vol.44 , pp. 146-150
    • Raife, T.1    Atkinson, B.2    Montgomery, R.3    Vesely, S.4    Friedman, K.5
  • 43
    • 84885483363 scopus 로고    scopus 로고
    • Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort
    • Bentley M.J., Wilson A.R., Rodgers G.M. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort. Vox Sang 2013, 105:313-318.
    • (2013) Vox Sang , vol.105 , pp. 313-318
    • Bentley, M.J.1    Wilson, A.R.2    Rodgers, G.M.3
  • 44
    • 84862783878 scopus 로고    scopus 로고
    • The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies
    • Cataland S.R., Yang S., Wu H.M. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies. Br J Haematol 2012, 157:501-503.
    • (2012) Br J Haematol , vol.157 , pp. 501-503
    • Cataland, S.R.1    Yang, S.2    Wu, H.M.3
  • 45
    • 43449135029 scopus 로고    scopus 로고
    • Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
    • Jin M., Casper T.C., Cataland S.R., Kennedy M.S., Lin S., Li Y.J., et al. Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse. Br J Haematol 2008, 141:651-658.
    • (2008) Br J Haematol , vol.141 , pp. 651-658
    • Jin, M.1    Casper, T.C.2    Cataland, S.R.3    Kennedy, M.S.4    Lin, S.5    Li, Y.J.6
  • 46
    • 84945700670 scopus 로고
    • Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3, B7 haplotype
    • Carreras L., Romero R., Requesens C., Oliver A.J., Carrera M., Clavo M., et al. Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3, B7 haplotype. JAMA 1981, 245:602-604.
    • (1981) JAMA , vol.245 , pp. 602-604
    • Carreras, L.1    Romero, R.2    Requesens, C.3    Oliver, A.J.4    Carrera, M.5    Clavo, M.6
  • 47
    • 0016403925 scopus 로고
    • Letter: haemolytic-uraemic syndrome: evidence for intravascular C3 activation
    • Stuhlinger W., Kourilsky O., Kanfer A., Sraer J.D. Letter: haemolytic-uraemic syndrome: evidence for intravascular C3 activation. Lancet 1974, 2:788-789.
    • (1974) Lancet , vol.2 , pp. 788-789
    • Stuhlinger, W.1    Kourilsky, O.2    Kanfer, A.3    Sraer, J.D.4
  • 48
    • 0032950690 scopus 로고    scopus 로고
    • Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura
    • Noris M., Ruggenenti P., Perna A., Orisio S., Caprioli J., Skerka C., et al. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura. J Am Soc Nephrol 1999, 10:281-293.
    • (1999) J Am Soc Nephrol , vol.10 , pp. 281-293
    • Noris, M.1    Ruggenenti, P.2    Perna, A.3    Orisio, S.4    Caprioli, J.5    Skerka, C.6
  • 51
    • 84876044818 scopus 로고    scopus 로고
    • Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults
    • Fremeaux-Bacchi V., Fakhouri F., Garnier A., Bienaime F., Dragon-Durey M.A., Ngo S., et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 2013, 8:554-562.
    • (2013) Clin J Am Soc Nephrol , vol.8 , pp. 554-562
    • Fremeaux-Bacchi, V.1    Fakhouri, F.2    Garnier, A.3    Bienaime, F.4    Dragon-Durey, M.A.5    Ngo, S.6
  • 52
    • 80052160688 scopus 로고    scopus 로고
    • Advances in assay of complement function and activation
    • Harboe M., Thorgersen E.B., Mollnes T.E. Advances in assay of complement function and activation. Adv Drug Deliv Rev 2011, 63:976-987.
    • (2011) Adv Drug Deliv Rev , vol.63 , pp. 976-987
    • Harboe, M.1    Thorgersen, E.B.2    Mollnes, T.E.3
  • 54
    • 84885339216 scopus 로고    scopus 로고
    • Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura
    • Wu T.C., Yang S., Haven S., Holers V.M., Lundberg A.S., Wu H., et al. Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura. J Thromb Haemost 2013, 11:1925-1927.
    • (2013) J Thromb Haemost , vol.11 , pp. 1925-1927
    • Wu, T.C.1    Yang, S.2    Haven, S.3    Holers, V.M.4    Lundberg, A.S.5    Wu, H.6
  • 55
    • 33644846673 scopus 로고    scopus 로고
    • Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
    • Howard M.A., Williams L.A., Terrell D.R., Duvall D., Vesely S.K., George J.N. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006, 46:154-156.
    • (2006) Transfusion , vol.46 , pp. 154-156
    • Howard, M.A.1    Williams, L.A.2    Terrell, D.R.3    Duvall, D.4    Vesely, S.K.5    George, J.N.6
  • 56
    • 80052290190 scopus 로고    scopus 로고
    • Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy
    • Bouts A., Monnens L., Davin J.C., Struijk G., Spanjaard L. Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy. Pediatr Nephrol 2011, 26:1919-1920.
    • (2011) Pediatr Nephrol , vol.26 , pp. 1919-1920
    • Bouts, A.1    Monnens, L.2    Davin, J.C.3    Struijk, G.4    Spanjaard, L.5
  • 57
    • 84879121370 scopus 로고    scopus 로고
    • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
    • Hillmen P., Muus P., Roth A., Elebute M.O., Risitano A.M., Schrezenmeier H., et al. Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 2013, 162:62-73.
    • (2013) Br J Haematol , vol.162 , pp. 62-73
    • Hillmen, P.1    Muus, P.2    Roth, A.3    Elebute, M.O.4    Risitano, A.M.5    Schrezenmeier, H.6
  • 58
    • 33748904355 scopus 로고    scopus 로고
    • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    • Hillmen P., Young N.S., Schubert J., Brodsky R.A., Socie G., Muus P., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006, 355:1233-1243.
    • (2006) N Engl J Med , vol.355 , pp. 1233-1243
    • Hillmen, P.1    Young, N.S.2    Schubert, J.3    Brodsky, R.A.4    Socie, G.5    Muus, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.